| Issue Date | Title | Author(s) |
| 2019-07-11 | Australia-modified Karnofsky Performance Scale and physical activity in COPD and lung cancer: an exploratory pooled data analysis. | Barbetta, C; Allgar, V; Maddocks, M; Ribeiro, C; Wilcock, A; Currow, DC; Phillips, J; Johnson, MJ |
| 2020-09-03 | COVID-19: guidance on palliative care from a European Respiratory Society international task force. | Janssen, DJA; Ekström, M; Currow, DC; Johnson, MJ; Maddocks, M; Simonds, AK; Tonia, T; Marsaa, K |
| 2018-11-05 | Efficacy of Anamorelin, a novel non-peptide ghrelin analogue, in patients with advanced non-small cell lung cancer (NSCLC) and Cachexia—Review and expert opinion | Currow, DC; Maddocks, M; Cella, D; Muscaritoli, M |
| 2023-08 | European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease. | Janssen, DJA; Bajwah, S; Boon, MH; Coleman, C; Currow, DC; Devillers, A; Vandendungen, C; Ekström, M; Flewett, R; Greenley, S; Guldin, M-B; Jácome, C; Johnson, MJ; Kurita, GP; Maddocks, M; Marques, A; Pinnock, H; Simon, ST; Tonia, T; Marsaa, K |
| 2016-01-01 | The need to research refractory breathlessness | Currow, DC; Abernethy, AP; Allcroft, P; Banzett, RB; Bausewein, C; Booth, S; Carrieri-Kohlman, V; Davidson, P; Disler, R; Donesky, DA; Dudgeon, D; Ekstrom, M; Farquhar, M; Higginson, I; Janssen, D; Jensen, D; Jolley, C; Krajnik, M; Laveneziana, P; McDonald, C; Maddocks, M; Morelot-Panzini, C; Moxham, J; Mularski, RA; Noble, S; O'Donnell, D; Parshall, MB; Pattinson, K; Phillips, J; Ross, J; Schwartzstein, RM; Similowski, T; Simon, ST; Smith, T; Wells, A; Yates, P; Yorke, J; Johnson, MJ |
| 2022-09-15 | Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness An Official ATS/AAHPM/HPNA/SWHPN Policy Statement | Sullivan, DR; Iyer, AS; Enguidanos, S; Reinke, LF; Campbell, ML; Courtright, KR; Cox, CE; Farquhar, M; Fasolino, TK; Fogelman, PM; Gershon, L; Gershon, T; Hartog, C; Janssen, DJA; Kross, EK; Lindell, KO; Luther, J; Maddocks, M; McPherson, ML; Meier, DE; Mularski, RA; Nelson, JE; Rabinowitz, E; Rushton, CH; Sloan, DH; Smallwood, N; Thornton, JD; Turnbull, AE; Wilkinson, AM |
| 2023 | Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial). | Sousa, MS; Martin, P; Johnson, MJ; Lind, M; Maddocks, M; Bullock, A; Agar, M; Chang, S; Kochovska, S; Kinchin, I; Morgan, D; Fazekas, B; Razmovski-Naumovski, V; Lee, JT; Itchins, M; Bray, V; Currow, DC; Matsubara, J |
| 2023-10 | Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. | McDonald, J; Sayers, J; Anker, SD; Arends, J; Balstad, TR; Baracos, V; Brown, L; Bye, A; Dajani, O; Dolan, R; Fallon, MT; Fraser, E; Griel, C; Grzyb, A; Hjermstad, M; Jamal-Hanjani, M; Jakobsen, G; Kaasa, S; McMillan, D; Maddocks, M; Philips, I; Ottestad, IO; Reid, KF; Sousa, MS; Simpson, MR; Vagnildhaug, OM; Skipworth, RJE; Solheim, TS; Laird, BJA; Cancer Cachexia Endpoints Working Group, |
